LobbyingAmerican Association of Blood Banks, Dba Association for the Advancement of Bloo lobbying by quarter
American Association of Blood Banks, Dba Association for the Advancement of Bloo's latest lobbying report covers Q2 2026, at under $5,000. Its first report covers Q4 2022; the issues it reports most are Health Issues.
American Association of Blood Banks, Dba Association for the Advancement of Bloo
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $0
- Last 4 quarters
- vs last quarter
- No record
- Q3 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
No lobbying spend in this period.
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $0 | 1 |
| Q1 2023 | $0 | 1 |
| Q2 2023 | $0 | 1 |
| Q3 2023 | $0 | 1 |
| Q4 2023 | $0 | 1 |
| Q1 2024 | $0 | 1 |
| Q2 2024 | $0 | 1 |
| Q3 2024 | $0 | 1 |
| Q4 2024 | $0 | 1 |
| Q1 2025 | $0 | 1 |
| Q2 2025 | $0 | 1 |
| Q3 2025 | $0 | 1 |
| Q4 2025 | $0 | 1 |
| Q1 2026 | $0 | 1 |
| Q2 2026 | $0 | 1 |
| Q3 2026 | $0 | 0 |
By issue
- Health issues$0 · 8 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES7 reports
- SENATE7 reports
Firms it paid
| Firm | ||
|---|---|---|
| In-houseAmerican Association of Blood Banks, Dba Association for the Advancement of Blood & Biotherapies | $0 | 15 quarters |
Former officials lobbying for it
No lobbyist with a covered position.
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/17for Q2 | In-house | Under $5,000 |
| 04/16for Q1 | In-house | Under $5,000 |
| 01/23for Q4 2025 | In-house | Under $5,000 |
| 25/10/15for Q3 2025 | In-house | Under $5,000 |
| 25/07/10for Q2 2025 | In-house | Under $5,000 |
| 25/04/11for Q1 2025 | In-house | Under $5,000 |
| 25/01/15for Q4 2024 | In-house | Under $5,000 |
| 24/10/15for Q3 2024 | In-house | Under $5,000 |
| 24/07/17for Q2 2024 | In-house | Under $5,000 |
| 24/04/17for Q1 2024 | In-house | Under $5,000 |
| 24/01/03for Q4 2023 | In-house | Under $5,000 |
| 23/11/17for Q3 2023 | In-house | Under $5,000 |
| 23/07/20for Q2 2023 | In-house | Under $5,000 |
| 23/04/12for Q1 2023 | In-house | Under $5,000 |
| 23/01/17for Q4 2022 | In-house | Under $5,000 |